Cassandra Ann Cesar is a Elmont, New York based nurse practitioner. Active license number of Cassandra Ann Cesar is F355799 for Family in New York. Her current practice location is 23814 116th Rd, Elmont. Patients can reach her at 516-285-1794 and her NPI number (Unique professional ID assigned by NPPES) is 1871035717. Cassandra Ann Cesar has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Cassandra Ann Cesar speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1871035717
NPI Enumeration Date:
09 Nov, 2016
NPI Last Update On:
05 Feb, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Cassandra Ann Cesar are as mentioned below.
License Number
Specialization
State
Status
F355799
Family
New York
Primary
327234
Licensed Practical Nurse
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Cassandra Ann Cesar 23814 116th Rd, Elmont, New York
Zip:
11003-4008
Phone Number:
516-318-3689
Patients can reach Cassandra Ann Cesar at 23814 116th Rd, Elmont, New York or can call to book an appointment on 516-285-1794.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 10 February, 2025.